Analysis of putative mucosal SHIV susceptibility factors during repeated DMPA treatments in pigtail macaques

scientific article

Analysis of putative mucosal SHIV susceptibility factors during repeated DMPA treatments in pigtail macaques is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1111/JMP.12188
P698PubMed publication ID26238265

P50authorSherif ZakiQ29381120
P2093author name stringJana Ritter
Katherine Butler
David Garber
Ellen N Kersh
Janet M McNicholl
Tara R Henning
Shanon Ellis
Jeltley Montague
P2860cites workComparison of the vaginal environment of Macaca mulatta and Macaca nemestrina throughout the menstrual cycleQ26827574
Research gaps in defining the biological link between HIV risk and hormonal contraceptionQ27002559
Hormonal contraceptive methods and risk of HIV acquisition in women: a systematic review of epidemiological evidenceQ27005890
The complexity of contraceptives: understanding their impact on genital immune cells and vaginal microbiota.Q27692596
Hormonal contraceptive use and women's risk of HIV acquisition: a meta-analysis of observational studiesQ30660068
Evaluation of pigtail macaques as a model for the effects of copper intrauterine devices on HIV infectionQ33818024
Long-term effect of depot medroxyprogesterone acetate on vaginal microbiota, epithelial thickness and HIV target cellsQ34229680
SHIV susceptibility changes during the menstrual cycle of pigtail macaquesQ34243579
Depot-medroxyprogesterone acetate does not reduce the prophylactic efficacy of emtricitabine and tenofovir disoproxil fumarate in macaquesQ34421999
A combined oral contraceptive affects mucosal SHIV susceptibility factors in a pigtail macaque (Macaca nemestrina) modelQ35164046
Depot medroxyprogesterone acetate increases immune cell numbers and activation markers in human vaginal mucosal tissuesQ36634806
Animal models for microbicide studiesQ37017688
Use of hormonal contraceptives and HIV acquisition in women: a systematic review of the epidemiological evidence.Q38122873
Physiologic doses of depot-medroxyprogesterone acetate do not increase acute plasma simian HIV viremia or mucosal virus shedding in pigtail macaquesQ42222740
Non-human primate models of hormonal contraception and HIV.Q42225882
The effect of one injection of Depo-Provera on the human vaginal epithelium and cervical ectopyQ44865495
Progesterone implants enhance SIV vaginal transmission and early virus loadQ45767734
High susceptibility to repeated, low-dose, vaginal SHIV exposure late in the luteal phase of the menstrual cycle of pigtail macaques.Q46034053
Hormonal synchronization of the menstrual cycles of pigtail macaques to facilitate biomedical research including modeling HIV susceptibility.Q51516274
P433issue5
P304page(s)286-295
P577publication date2015-08-04
P1433published inJournal of Medical PrimatologyQ15755599
P1476titleAnalysis of putative mucosal SHIV susceptibility factors during repeated DMPA treatments in pigtail macaques
P478volume44

Reverse relations

cites work (P2860)
Q40632328A Depot Medroxyprogesterone Acetate Dose That Models Human Use and Its Effect on Vaginal SHIV Acquisition Risk
Q33553821Genital Injury Signatures and Microbiome Alterations Associated With Depot Medroxyprogesterone Acetate Usage and Intravaginal Drying Practices
Q58700581Griffithsin carrageenan fast dissolving inserts prevent SHIV HSV-2 and HPV infections in vivo
Q47198102Hormonal Contraception and HIV-1 Acquisition: Biological Mechanisms
Q27311833Increases in Endogenous or Exogenous Progestins Promote Virus-Target Cell Interactions within the Non-human Primate Female Reproductive Tract
Q36284595Relationship of Estimated SHIV Acquisition Time Points During the Menstrual Cycle and Thinning of Vaginal Epithelial Layers in Pigtail Macaques